Skip to main content

6-K

Indivior Pharmaceuticals, Inc. (INDV)

6-K 2025-02-28 For: 2025-02-28
View Original
Added on July 07, 2026

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

________________________

Washington, D.C. 20549

_____________________

FORM 6-K

_____________________

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

For the month of February 2025

Commission File Number: 001-37835

________________________________________

Indivior PLC

________________________________________

10710 Midlothian Turnpike, Suite 125

North Chesterfield, Virginia 23235

(Address of principal executive office)

_______________________________

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F

Form 20-F ☒ Form 40-F ☐

EXHIBIT INDEX

Exhibit No. Description of Exhibit
99.1 Announcement sent to the London Stock Exchange on February 28,<br>2025, titled “Holding(s) in Company”.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Indivior PLC
Date: February 28, 2025 /s/<br>Kathryn Hudson
Name:<br>Kathryn Hudson
Title:<br>Company Secretary

a7694y-announcement

Exhibit 99.1

TR-1: Standard form for notification of major holdings

  1. Issuer Details

ISIN

GB00BN4HT335

Issuer Name

INDIVIOR PLC

UK or Non-UK Issuer

UK
  1. Reason for Notification
An acquisition or disposal of financial instruments;<br>Other

Comments

Application of Trading Book Exemption (see Section 11<br>below)
  1. Details of person subject to the notification obligation

Name

Morgan Stanley

City of registered office (if applicable)

Country of registered office (if applicable)

US
Name City<br>of registered office Country<br>of registered office
--- --- ---
Morgan<br>Stanley Wilmington,<br>Delaware USA
  1. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

City of registered office (if applicable)

Country of registered office (if applicable)

  1. Date on which the threshold was crossed or reached
25-Feb-2025
  1. Date on which Issuer notified
27-Feb-2025
  1. Total positions of person(s) subject to the notification obligation
% of voting rights attached to shares (total of 8.A) % of voting rights through financial instruments (total of 8.B 1 +<br>8.B 2) Total of both in % (8.A + 8.B) Total number of voting rights held in issuer
Resulting<br>situation on the date on which threshold was crossed or<br>reached 0.000000 0.000000 0.000000 0
Position<br>of previous notification (if applicable) 3.285654 2.037829 5.323483
  1. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible) Number of direct voting rights (DTR5.1) Number of indirect voting rights (DTR5.2.1) % of direct voting rights (DTR5.1) % of indirect voting rights (DTR5.2.1)
GB00BN4HT335 0 0.000000
Sub<br>Total 8.A 0 0.000000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument Expiration date Exercise/conversion period Number of voting rights that may be acquired if the instrument is<br>exercised/converted % of voting rights
Sub<br>Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument Expiration date Exercise/conversion period Physical or cash settlement Number of voting rights % of voting rights
Sub<br>Total 8.B2
  1. Information in relation to the person subject to the notification obligation
2. Full chain of controlled undertakings through which the voting<br>rights and/or the financial instruments are effectively held<br>starting with the ultimate controlling natural person or legal<br>entities (please add additional rows as necessary)
Ultimate controlling person Name of controlled undertaking % of voting rights if it equals or is higher than the notifiable<br>threshold % of voting rights through financial instruments if it equals or is<br>higher than the notifiable threshold Total of both if it equals or is higher than the notifiable<br>threshold
--- --- --- --- ---
Morgan<br>Stanley (Chain 1)
Morgan<br>Stanley (Chain 1) Morgan<br>Stanley Capital Management, LLC
Morgan<br>Stanley (Chain 1) Morgan<br>Stanley Smith Barney LLC
  1. In case of proxy voting

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

  1. Additional Information
The notification was triggered due to Morgan Stanley's total<br>applicable holding dropping below 5%. As a result, Morgan Stanley<br>has applied the trading book exemption (DTR 5.1.3R(4)) to its<br>remaining applicable holding of 4.979353% as of February 25,<br>2025.
  1. Date of Completion
27-Feb-2025
  1. Place Of Completion
Mumbai